Cargando…

Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden

BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are widespread and persistent pollutants that have been associated with elevated cholesterol levels. However, data on incident cardiovascular disease (CVD) is lacking. OBJECTIVES: We investigated the association of exposure to PFAS with risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schillemans, Tessa, Donat-Vargas, Carolina, Lindh, Christian H., de Faire, Ulf, Wolk, Alicja, Leander, Karin, Åkesson, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Environmental Health Perspectives 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919955/
https://www.ncbi.nlm.nih.gov/pubmed/35285690
http://dx.doi.org/10.1289/EHP9791
_version_ 1784669028063641600
author Schillemans, Tessa
Donat-Vargas, Carolina
Lindh, Christian H.
de Faire, Ulf
Wolk, Alicja
Leander, Karin
Åkesson, Agneta
author_facet Schillemans, Tessa
Donat-Vargas, Carolina
Lindh, Christian H.
de Faire, Ulf
Wolk, Alicja
Leander, Karin
Åkesson, Agneta
author_sort Schillemans, Tessa
collection PubMed
description BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are widespread and persistent pollutants that have been associated with elevated cholesterol levels. However, data on incident cardiovascular disease (CVD) is lacking. OBJECTIVES: We investigated the association of exposure to PFAS with risk of myocardial infarction and stroke and, subsidiary, with baseline blood lipids. METHODS: This population-based nested case–control study included first incident myocardial infarction and stroke cases with matched controls from two Swedish cohorts: the Swedish Mammography Cohort-Clinical (SMC-C) and the Cohort of 60-year-olds (60YO). Baseline blood sampling occurred during 2003–2009 and 1997–1999 with follow-up through 2017 and 2014 for the SMC-C and the 60YO, respectively. Eight plasma PFAS concentrations were measured using targeted liquid chromatography–triple quadrupole mass spectrometry. Five of these were quantifiable in both cohorts; individual values and their standardized sum were categorized into tertiles based on the controls. First incident myocardial infarction ([Formula: see text]) and ischemic stroke ([Formula: see text]) cases were ascertained via linkage to the National Inpatient Register and the Cause of Death Register. Controls were randomly selected from each cohort after matching for age, sex, and sample date. Baseline blood lipids were measured in plasma or serum after overnight fasting. RESULTS: Among the 1,528 case–control subjects, the mean (standard deviation) age was 66 (7.7) y and 67% of them were women. In multivariable-adjusted analyses, the third tertile of the standardized sum of five PFAS associated with higher cholesterol and lower triglyceride levels among controls at baseline ([Formula: see text]). The corresponding results were [Formula: see text] [95% confidence interval (CI): 0.53, 0.93] for CVD, 0.60 (95% CI: 0.39, 0.92) for myocardial infarction, and 0.83 (95% CI: 0.46, 1.50) for stroke. DISCUSSION: This study indicated that exposure to PFAS, although associated with increased cholesterol levels, did not associate with an increased risk of myocardial infarction, stroke, or their composite end point. The findings improve our knowledge on potential health effects of environmental contaminants in the CVD context. https://doi.org/10.1289/EHP9791
format Online
Article
Text
id pubmed-8919955
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Environmental Health Perspectives
record_format MEDLINE/PubMed
spelling pubmed-89199552022-03-17 Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden Schillemans, Tessa Donat-Vargas, Carolina Lindh, Christian H. de Faire, Ulf Wolk, Alicja Leander, Karin Åkesson, Agneta Environ Health Perspect Research BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are widespread and persistent pollutants that have been associated with elevated cholesterol levels. However, data on incident cardiovascular disease (CVD) is lacking. OBJECTIVES: We investigated the association of exposure to PFAS with risk of myocardial infarction and stroke and, subsidiary, with baseline blood lipids. METHODS: This population-based nested case–control study included first incident myocardial infarction and stroke cases with matched controls from two Swedish cohorts: the Swedish Mammography Cohort-Clinical (SMC-C) and the Cohort of 60-year-olds (60YO). Baseline blood sampling occurred during 2003–2009 and 1997–1999 with follow-up through 2017 and 2014 for the SMC-C and the 60YO, respectively. Eight plasma PFAS concentrations were measured using targeted liquid chromatography–triple quadrupole mass spectrometry. Five of these were quantifiable in both cohorts; individual values and their standardized sum were categorized into tertiles based on the controls. First incident myocardial infarction ([Formula: see text]) and ischemic stroke ([Formula: see text]) cases were ascertained via linkage to the National Inpatient Register and the Cause of Death Register. Controls were randomly selected from each cohort after matching for age, sex, and sample date. Baseline blood lipids were measured in plasma or serum after overnight fasting. RESULTS: Among the 1,528 case–control subjects, the mean (standard deviation) age was 66 (7.7) y and 67% of them were women. In multivariable-adjusted analyses, the third tertile of the standardized sum of five PFAS associated with higher cholesterol and lower triglyceride levels among controls at baseline ([Formula: see text]). The corresponding results were [Formula: see text] [95% confidence interval (CI): 0.53, 0.93] for CVD, 0.60 (95% CI: 0.39, 0.92) for myocardial infarction, and 0.83 (95% CI: 0.46, 1.50) for stroke. DISCUSSION: This study indicated that exposure to PFAS, although associated with increased cholesterol levels, did not associate with an increased risk of myocardial infarction, stroke, or their composite end point. The findings improve our knowledge on potential health effects of environmental contaminants in the CVD context. https://doi.org/10.1289/EHP9791 Environmental Health Perspectives 2022-03-14 /pmc/articles/PMC8919955/ /pubmed/35285690 http://dx.doi.org/10.1289/EHP9791 Text en https://ehp.niehs.nih.gov/about-ehp/licenseEHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
spellingShingle Research
Schillemans, Tessa
Donat-Vargas, Carolina
Lindh, Christian H.
de Faire, Ulf
Wolk, Alicja
Leander, Karin
Åkesson, Agneta
Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
title Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
title_full Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
title_fullStr Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
title_full_unstemmed Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
title_short Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
title_sort per- and polyfluoroalkyl substances and risk of myocardial infarction and stroke: a nested case–control study in sweden
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919955/
https://www.ncbi.nlm.nih.gov/pubmed/35285690
http://dx.doi.org/10.1289/EHP9791
work_keys_str_mv AT schillemanstessa perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden
AT donatvargascarolina perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden
AT lindhchristianh perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden
AT defaireulf perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden
AT wolkalicja perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden
AT leanderkarin perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden
AT akessonagneta perandpolyfluoroalkylsubstancesandriskofmyocardialinfarctionandstrokeanestedcasecontrolstudyinsweden